Antibody half-life extension refers to strategies used to prolong the time that therapeutic antibodies remain active in the body, increasing their effectiveness and reducing the need for frequent dosing. The half-life of an antibody is the time it takes for its concentration in the bloodstream to reduce by half, and extending this duration is crucial for improving the efficiency of antibody-based treatments.